Clinical research

PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study

EuroIntervention 2010;6:220-226.

Yves-Laurent Bayard
Yves-Laurent Bayard1, MD; Heyder Omran2, MD; Petr Neuzil3, MD; Leif Thuesen4, MD; Maximilian Pichler5, MD; Edward Rowland6, MD; Angelo Ramondo7, MD; Witold Ruzyllo8, MD; Werner Budts9, MD; Gilles Montalescot10, MD; Pedro Brugada11, MD; Patrick W. Serruys12, MD; Alec Vahanian13, MD; Jean-François Piéchaud14, MD; Antonio Bartorelli15, MD; Jean Marco16, MD; Peter Probst17, MD; Karl-Heinz Kuck18, MD; Stefan H. Ostermayer1, MD; Fra
1. CardioVascular Center Frankfurt, Sankt Katharinen, Frankfurt, Germany; 2. Sankt Marien Hospital, Academic Center of the University of Bonn, Bonn, Germany; 3. Na Homolce Hospital, Prague, Czech Republic; 4. Skejby Sygehus, Aarhus, Denmark; 5. Landeskran

Aims: The European PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) study was performed to determine the safety and efficacy of left atrial appendage occlusion by cathete

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

left atrial appendage closureatrial fibrillationstrokeprevention
Read next article
A randomised comparison of novolimus-eluting and zotarolimus-eluting coronary stents: 9-month follow-up results of the EXCELLA II study

Latest news